Continued use of beta-blockers for hypertension during noncardiac surgery can raise the risk of major adverse cardiac events (MACE) and all-cause mortality within 30 days in a relatively low-risk population, suggests new research that is in line with earlier studies that generally included higher-risk patients.
Hormone therapy might be protective in postmenopausal women during a first myocardial infarction (MI), but could increase the risk — and severity — of a second, results from an observational Finnish study suggest.
In the first year after a postmenopausal women discontinues hormone therapy, her risk for cardiovascular mortality is higher than if she had continued the therapy, according to an observational study.
A new study suggests that menopausal women who experience frequent hot flashes could be at increased risk for subclinical cardiovascular disease.
Two new analyses of the Multi-Ethnic Study of Atherosclerosis (MESA) provide evidence that the use of coronary artery calcium (CAC) screening can reclassify patients at risk from cardiovascular disease and better identify those who would most benefit from statin therapy compared with current guidelines.
For patients with first-time unprovoked venous thromboembolism (VTE), oral sulodexide may help stave off future flare-ups without causing serious safety risks, suggests new research published online September 25, 2015 in Circulation..
Although the link between some chemotherapy agents and cardiac damage is well-known, new research published online September 28, 2015 in Heart, suggests that some cancers on their own may contribute to cardiac dysfunction.
One in eight young women with acute Myocardial Infarction (MI) have a type of MI that falls in the “unclassified” category under a current classification system, researchers report; they propose a new taxonomy that better captures different presentations in young women.
The American College of Cardiology, American Heart Association, and the Heart Rhythm Society (ACC/AHA/HRS) have published new guidelines for the management of patients with supraventricular tachycardia (SVT).